Year archive

D&D Pharmatech Inc. — 2026 filings

All 19 regulatory filings released by D&D Pharmatech Inc. (347850) in 2026, sourced directly from the official regulator.

19 Filings

2026 Period

2026 filings (19)

Filing	Released	Lang
기업설명회(IR)개최 Regulatory Filings	2026-06-02	Korean
[기재정정]투자판단관련주요경영사항(임상시험결과) (대사이상지방간염 (MASH) 치료제 DD01의 미국 임상 제2상 Topline data 수령) Regulatory Filings	2026-05-27	Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고 Board/Management Information	2026-05-18	Korean
분기보고서 (2026.03) Interim / Quarterly Report Q1 2026	2026-05-15	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-05-15	Korean
증권발행결과(자율공시) (제2회차 CB) Capital/Financing Update	2026-04-30	Korean
단일판매ㆍ공급계약체결 Regulatory Filings	2026-04-16	Korean
주요사항보고서(전환사채권발행결정) Capital/Financing Update	2026-04-15	Korean
정기주주총회결과 Declaration of Voting Results & Voting Rights Announcements	2026-03-30	Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고 Board/Management Information	2026-03-30	Korean
사업보고서 (2025.12) Annual Report FY 2025	2026-03-20	Korean
감사보고서제출 Audit Report / Information FY 2025	2026-03-20	Korean
주주총회소집공고 Proxy Solicitation & Information Statement	2026-03-03	Korean
의결권대리행사권유참고서류 Proxy Solicitation & Information Statement	2026-03-03	Korean
주주총회집중일개최사유신고 Regulatory Filings	2026-03-03	Korean
기업설명회(IR)개최 Investor Presentation	2026-02-20	Korean
매출액또는손익구조30%(대규모법인은15%)이상변동 Earnings Release FY 2025	2026-02-13	Korean
주주총회소집결의 AGM Information	2026-02-13	Korean
기업설명회(IR)개최 Investor Presentation	2026-02-02	Korean